Image For Activity Cover
Host 7167 Contingency Management for Treating Stimulant Use Disorder: Theories, Principles, and Practice
Faculty
Albert L. Hasson received his MSW from the UCLA, and has worked in the field of addiction medicine as a researcher, treatment provider and trainer since 1977. He began his career working as a research associate at the Sepulveda Veterans Administration Medical Center evaluating naltrexone for the treatment of opioid use disorders. Mr. Hasson participated in the development of the evidence-based Matrix Model, a cognitive behavioral intervention for the treatment of stimulant disorders, and established the Matrix Institute on Addictions, Los Angeles, an opioid treatment program serving individuals with co-occurring mental and physical health and substance use disorders. During his role as the Node Coordinator of the Pacific Region Node of the National Institute on Drug Abuse, Clinical Trials Network, Mr. Hasson provided oversight for the development and conduct of large, multi-site clinical trials evaluating medications and behavioral therapies for substance use disorders. As a project director and trainer for the Pacific Southwest Addiction Technology Transfer Center at the UCLA Integrated Substance Abuse Programs, Mr. Hasson trained mental health, corrections and substance use disorder providers on Motivational Interviewing, Cognitive Behavioral Therapy, Contingency Management, Co-Occurring Disorders, the American Society of Addiction Medicine Criteria, and Medications for Opioid Use Disorder. Mr. Hasson retired from the UCLA Integrated Substance Abuse Programs and is currently working as a private consultant.
Learning Objectives

Course objectives

  1. Review evidence base for behavioral therapies and treatment practices for stimulant use disorder. 

  1. Identify strategies to address clinical challenges related to co-occurring disorders. 

  1. Describe key considerations to effectively engage and retain patients in treatment. 

Summary
Availability: On-Demand
Expires on Apr 08, 2027
Cost: FREE
Credit Offered:
1.5 Attendance Credits
Recommended
 
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.



Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

 
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email PCSS-MOUD.

ORN
opioidresponsenetwork.org

Powered By